Johnson & Johnson Rallybio Corp Transaction History
Johnson & Johnson
- $314 Million
- Q3 2024
A detailed history of Johnson & Johnson transactions in Rallybio Corp stock. As of the latest transaction made, Johnson & Johnson holds 3,636,363 shares of RLYB stock, worth $3.45 Million. This represents 1.36% of its overall portfolio holdings.
Number of Shares
3,636,363
Previous 3,636,363
-0.0%
Holding current value
$3.45 Million
Previous $4.87 Million
12.68%
% of portfolio
1.36%
Previous 1.68%
Shares
1 transactions
Others Institutions Holding RLYB
# of Institutions
52Shares Held
31.9MCall Options Held
0Put Options Held
0-
Viking Global Investors LP4.19MShares$3.99 Million0.02% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA3.63MShares$3.45 Million1.69% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY3.3MShares$3.14 Million3.98% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX3.03MShares$2.88 Million0.08% of portfolio
-
Pivotal Bio Venture Partners Investment Advisor LLC San Francisco, CA2.4MShares$2.28 Million2.22% of portfolio
About Rallybio Corp
- Ticker RLYB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,132,000
- Market Cap $30.5M
- Description
- Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...